HK1199453A1 - A crystal form of icaritin compound, a medicament comprising the crystalline form and use thereof - Google Patents

A crystal form of icaritin compound, a medicament comprising the crystalline form and use thereof

Info

Publication number
HK1199453A1
HK1199453A1 HK14113110.2A HK14113110A HK1199453A1 HK 1199453 A1 HK1199453 A1 HK 1199453A1 HK 14113110 A HK14113110 A HK 14113110A HK 1199453 A1 HK1199453 A1 HK 1199453A1
Authority
HK
Hong Kong
Prior art keywords
icaritin
medicament
compound
crystalline form
crystal form
Prior art date
Application number
HK14113110.2A
Other languages
Chinese (zh)
Inventor
孟坤湯城張波
Original Assignee
北京盛諾基醫藥科技有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 北京盛諾基醫藥科技有限公司 filed Critical 北京盛諾基醫藥科技有限公司
Publication of HK1199453A1 publication Critical patent/HK1199453A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
HK14113110.2A 2014-05-05 2014-12-31 A crystal form of icaritin compound, a medicament comprising the crystalline form and use thereof HK1199453A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410185323.2A CN103936705B (en) 2014-05-05 2014-05-05 The crystal formation of A Kelading compound, the medicine containing this crystal formation and purposes

Publications (1)

Publication Number Publication Date
HK1199453A1 true HK1199453A1 (en) 2015-07-03

Family

ID=51184617

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14113110.2A HK1199453A1 (en) 2014-05-05 2014-12-31 A crystal form of icaritin compound, a medicament comprising the crystalline form and use thereof

Country Status (3)

Country Link
CN (1) CN103936705B (en)
HK (1) HK1199453A1 (en)
TW (1) TWI660951B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103936705B (en) * 2014-05-05 2015-10-21 北京盛诺基医药科技有限公司 The crystal formation of A Kelading compound, the medicine containing this crystal formation and purposes
CN105106196A (en) * 2014-09-16 2015-12-02 北京盛诺基医药科技有限公司 Purposes of icaritin in preparing medicaments for inhibiting liver cancer stem cells
CN104230870A (en) * 2014-09-16 2014-12-24 北京盛诺基医药科技有限公司 Icaritin compound and application thereof
CN106148454B (en) * 2015-03-24 2021-01-26 北京珅奥基医药科技有限公司 Preparation method of baohuoside I
CN110699263B (en) * 2019-10-29 2021-05-11 浙江工业大学 Aspergillus niger YH-6 and application thereof in improving content of icaritin in epimedium

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101302548B (en) * 2007-05-09 2011-04-13 北京珅奥基医药科技有限公司 Preparation of icaritin
CN103936705B (en) * 2014-05-05 2015-10-21 北京盛诺基医药科技有限公司 The crystal formation of A Kelading compound, the medicine containing this crystal formation and purposes

Also Published As

Publication number Publication date
CN103936705A (en) 2014-07-23
TW201609683A (en) 2016-03-16
CN103936705B (en) 2015-10-21
TWI660951B (en) 2019-06-01

Similar Documents

Publication Publication Date Title
ZA201607773B (en) Cyclopropanamine compound and use thereof
EP3436455A4 (en) Novel salts and crystals
EP3192451A4 (en) Medical hook
EP3204360A4 (en) Therapeutic compounds and uses thereof
IL246757B (en) Novel insulin derivatives and the medical uses hereof
EP3131877A4 (en) Guanidine compounds and use thereof
EP3222614A4 (en) Biguanide compound and use thereof
EP3109240A4 (en) Triazine compound and use thereof for medical purposes
EP3341404A4 (en) Novel insulin analogs and use thereof
IL251940B (en) Dihydropyrimidin-2-one compounds and medical use thereof
EP2905006B8 (en) Device for discriminating the stages of sleep of a patient
HK1199453A1 (en) A crystal form of icaritin compound, a medicament comprising the crystalline form and use thereof
ZA201801134B (en) Hydroxytriazine compound and medical use thereof
EP3197885A4 (en) Heterocyclic compounds and use thereof
IL250729B (en) Pyrazolothiazole compound and medicine comprising same
EP3170820A4 (en) Benzothiazole compound and medicine containing same
EP3194628A4 (en) Antisense compounds and uses thereof
EP3202374A4 (en) Orthosis
PT2910223T (en) Plaster with medication dispenser
EP3194591A4 (en) Antisense compounds and uses thereof
GB201508787D0 (en) Pharmaceutically active compounds